Background and Rationale Immunoglobulin M (IgM) and Waldenström’s macroglobulinaemia (WM) have emerged as significant clinical entities, particularly in relation to […]
Overview of AMAN and Guillain-Barré Syndrome Acute Motor Axonal Neuropathy (AMAN) is a subtype of Guillain-Barré Syndrome (GBS), which primarily
Study Overview This research aims to assess the performance of the KFLC index threshold in diagnosing multiple sclerosis (MS) within
Study Overview This study undertakes an evaluation of efgartigimod, a human IgG1 antibody Fc fragment, specifically its effectiveness and safety
Mechanistic Pathways of PI3K/Akt/mTOR and JAK/STAT The interplay between the PI3K/Akt/mTOR and JAK/STAT signaling pathways plays a crucial role in
Study Overview The investigation into the long-term safety and efficacy of Efgartigimod PH20 for cases of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Study Overview The research aimed at exploring the potential repurposing of valsartan, a medication primarily indicated for hypertension and heart
FcRn Inhibitors Mechanism of Action FcRn inhibitors target the neonatal Fc receptor (FcRn), a crucial protein responsible for regulating the
FcRn inhibitors in the treatment of CIDP Read Post »
Background on Guillain-Barré Syndrome Guillain-Barré Syndrome (GBS) is an acute neurological disorder characterized by the rapid onset of muscle weakness
Background and Context Anti-MAG antibody-associated neuropathy is a rare and often misunderstood condition that involves peripheral nerve damage mediated by
Anti-MAG-associated neuropathy: a case report and literature review Read Post »
